2024 - Canadian IP Year in Review

People

Smart & Biggar is Canada’s largest and highest ranked intellectual property firm. Our reputation and strength is a measure of the quality of our people, and we are proud to have the broadest and deepest bench for IP in Canada. With over 100 lawyers, patent agents and trademark agents, we offer legal expertise and technological knowledge across a wide range of industries and scientific and engineering disciplines, with leaders in every field.

Services

Today’s fast-paced innovation economy demands a higher level of expertise and attention to detail when it comes to IP. Our highly skilled team of lawyers, patent agents and trademark agents advise clients on a wide variety of strategic business, brand and technology matters leveraging their deep expertise in intellectual property to help them succeed with IP.

Industries

Across all industries, intellectual property is at the heart of innovation and is key to accelerating business value and growth. Developing a clear IP strategy and knowing how to tap and leverage IP to align with business goals can unlock competitive advantages and make the difference between industry leaders and followers.

Insights

At the forefront of IP in Canada, and actively involved as leaders in industry committees and associations, we stay up-to-date and proactively report on the latest developments in intellectual property law in Canada and around the world. Breaking IP news, changes in the law, important new decisions, and information on key IP issues are provided here through our IP publications and resources.

Careers

Many of the world's most commercially important innovators and most prominent brands trust Smart & Biggar to protect and enforce their IP and to provide them with strategic IP counsel. We have developed a reputation as a firm of talented lawyers and patent and trademark agents with integrity, business savvy and tremendous acumen. That’s why we look for the brightest people with combined talent and strengths in law, business, science and technology.

Who we are

Smart & Biggar is widely recognized as Canada’s leading firm for intellectual property, and with over 100 lawyers, patent agents and trademark agents in five offices, we are also Canada’s largest firm focused purely on IP and related specialty areas.

Our 2024 year-in-review resource features essential updates on Canadian litigation, trademarks, patents, life sciences IP and regulatory law. Read our articles, webinars and top 10 articles of 2024.

Year in Review Webinars

Canadian patent law 2024: a year in review

SpeakersAndrea Berenbaum, Ryan De Vries and Michael Sgro
Feb, 2025 12:00 PM - 01:00 PM
2024 was an active year in Canadian patent law. Our presenters provide an annual summary of key developments in Canadian patent law.
Canadian trademark law 2024: a year in review

SpeakersPelle Berends, Tierney GB Deluzio, Meika Ellis and Kwan T. Loh
Feb, 2025 12:00 PM - 01:00 PM
Our presenters deliver a roundup of Canadian trademark law, highlighting some of the most important new cases and practice directions from 2024.
Canadian IP litigation 2024: a year in review

SpeakersMatthew Burt, Daniel Davies and Jean-Sébastien Dupont
Feb, 2025 12:00 PM - 01:00 PM
This webinar provides an overview of important court decisions, changes to rules, practice notices and other developments that shaped the Canadian IP landscape in 2024.

Top 10 Most-Read IP Insights of 2024

The OQLF’s new guidelines: practical resources for trademarks on products
A practical guide to Canada’s new Patent Term Adjustment (PTA) system
Steps to consider before sending a cease-and-desist letter
Ghost in the machine: AI and patent protection
Artificial intelligence (AI) advocacy in the Federal Court
False alarm: the risks of groundless online takedown complaints
Trademark owners, beware: protecting your brand in the era of trademark scams
CIPO’s new Specificity Guidelines for goods and services: what you need to know
Supporting Canada’s green transition: the untapped potential of CIPO’s Green Technologies Program
Angelcare and Playtex seal another win against patent infringer Munchkin

View all IP Insights

Top 10 Most-Read Rx IP Updates of 2024

Update on biosimilars in Canada – March 2024
Federal Court finds PMPRB reasonably concluded Galderma’s patent claiming 0.3% adapalene “pertained to” 0.1% adapalene DIFFERIN
Federal Court of Appeal affirms paliperidone palmitate claims are not unpatentable methods of medical treatment
Evolving pharmacy landscape signals more stringent regulatory scrutiny of “patient steering”
LUMIGAN RC formulation patent found valid and infringed
Twice is not nice – second notice of allegation may be abusive
Boehringer Ingelheim succeeds in nintedanib PMNOC action against JAMP
U.S. FDA authorizes Florida plan to import drugs in bulk from Canada
Discussion Guide for PMPRB Phase 2 Consultations on New Guidelines outlines proposed new framework for patented medicine price review
PM(NOC) Regulations: seven-year anniversary of major amendments

View all Rx IP Updates

People

Search People

Services

Protect IP

Enforce IP

Grow IP